Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase-Reference-Cited by-同舟云学术

Identification of ML251, a Potent Inhibitor of T. brucei and T. cruzi Phosphofructokinase

Published:2013-11-08 Issue:1 Volume:5 Page:12-17
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Brimacombe Kyle R.¹,Walsh Martin J.¹,Liu Li¹,Vásquez-Valdivieso Montserrat G.²,Morgan Hugh P.²,McNae Iain²,Fothergill-Gilmore Linda A.²,Michels Paul A. M.³,Auld Douglas S.¹,Simeonov Anton¹,Walkinshaw Malcolm D.²,Shen Min¹,Boxer Matthew B.¹

Affiliation:

1. National Center for Advancing Translational Sciences, National Institutes of Health, 9800 Medical Center Drive, Rockville, Maryland 20850, United States

2. Centre for Translational and Chemical Biology, School of Biological Sciences, University of Edinburgh, Michael Swann Building, The King’s Buildings, Mayfield Road, Edinburgh EH9 3JR, U.K.

3. Research Unit for Tropical Diseases, de Duve Institute and Laboratory of Biochemistry, Université catholique de Louvain, Avenue Hippocrate 74, B-1200 Brussels, Belgium

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml400259d

Reference16 articles.

1. Glycolysis as a target for the design of new anti-trypanosome drugs

2. Priorities for the Elimination of Sleeping Sickness

3. The trypanosomiases

4. Chemotherapy against human African trypanosomiasis: Is there a road to success?

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Esters of Quinoxaline-7-Carboxylate 1,4-di-N-Oxide as Potential Inhibitors of Glycolytic Enzymes of Entamoeba histolytica: In silico Approach;Current Computer-Aided Drug Design;2024-04

2. PEX1 is essential for glycosome biogenesis and trypanosomatid parasite survival;Frontiers in Cellular and Infection Microbiology;2024-03-06

3. Polyamine Metabolism for Drug Intervention in Trypanosomatids;Pathogens;2024-01-16

4. Potential therapies targeting nuclear metabolic regulation in cancer;MedComm;2023-11-29

5. Recent research progress on small molecule compounds and its derivatives of antiparasitic drugs;Chinese Chemical Letters;2023-10